Search

everythinglearnresearchcommunity

for

Search:↓

A new method was developed to make a compound used in finasteride and epristeride with a 69% yield.

Three specific 4-azasteroid-2-oximes showed strong enzyme inhibition, but less than finasteride.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

Both Diane 35 combinations effectively and safely reduce hirsutism and acne, with potential for better results if treatment extends beyond 12 months.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Depo-Provera effectively prevents pregnancy but has many side effects and safety concerns, leading to its ban in the U.S.

GnRH-a or orchiectomy is more effective than anti-androgens for managing hormone levels in transgender women.

Chlormadinone acetate is useful for birth control and treating various hormonal issues.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

Two women had skin reactions from a hair loss treatment and got better after stopping use.

The treatment significantly reduced hair growth and male hormone levels in hirsute women.

COCs often cause nausea, vomiting, and hair loss, while Depo-Provera is linked to weight gain.

Using β-cyclodextrin derivatives improves the solubility and bioavailability of steroidal drugs.

Diane and Androcur 10 improved acne and seborrhea in most women, and hirsutism and alopecia in about half.

Estrogen alone may effectively suppress testosterone in some transfeminine individuals.

Transgender females can reach their target estrogen levels using estradiol patches, especially if oral treatments fail or if they're at risk for blood clots. Often, the highest dose patch is needed.

Norgestimate is the most effective birth control progestin for reducing an enzyme linked to acne and excessive hair growth in women.

Hormonal male contraception is effective and could be market-ready, but more research is needed to ensure safety for all ethnic groups.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

New compounds may help treat prostate issues without affecting androgen receptors.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Menthol-based microemulsions improve skin delivery of finasteride and silodosin.

Both finasteride and drospirenone treatments improved symptoms and increased pregnancy rates in women with polycystic ovary syndrome.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

Both oral contraceptives reduced acne effectively and had similar positive effects on skin oiliness and hair growth.

Oral contraceptives with desogestrel and drospirenone improve PCOS symptoms.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.

The treatment slightly increased hair growth and was safe for most women.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.